17β-Estradiol rapid stimulation of rat aorta NOS activity is prevented by oestrogen deficiency

Maturitas

Volumn 43, Issue 1, 2002, Pages 55-64

  Massheimer, Virginia ^a   Polini, Nélida ^a   Alvarez, Cristina ^a   Benozzi, Silivia ^a   Selles, Juana ^a  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

Author keywords

NOS; Oestrogen deficiency; Rat aorta

Indexed keywords

CITRULLINE; ESTRADIOL; ESTROGEN; NITRIC OXIDE SYNTHASE; TESTOSTERONE; TRITIUM; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ESTROGEN BLOOD LEVEL; ESTROGEN DEFICIENCY; FEMALE; ISOLATED ARTERY; NONHUMAN; OVARIECTOMY; RAT; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME; ANIMAL; BLOOD; DOSE RESPONSE; DRUG ANTAGONISM; IN VITRO STUDY; MALE; METABOLISM; THORACIC AORTA; WISTAR RAT;

ANIMALS; AORTA, THORACIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OVARIECTOMY; PLATELET AGGREGATION; RATS; RATS, WISTAR;

EID: 0037200818     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(02)00163-9     Document Type: Article

References (38)

1. Stampfer M.J., Colditz G.A., Willet W.C., et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' Health Study. New Engl. J. Med. 325:1991;156-162.
2. Gruchow H., Anderson A., Barboriak J., Sobocinski K. Postmenopausal use of estrogen and occlusion of coronary arteries. Am. Heart J. 115:1988;954-963.
3. Miller V.M. Modulation of endothelium-dependent and vascular smooth muscle responses by estrogens. Phlebiology. 224:1988;19-22.
4. Herrington D.M., Braden G.A., Williams J.K., Morgan T.M. Endothelium dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am. J. Cardiol. 73:1994;951-952.
5. Guilligan D.M., Badar D.M., Panza J.A., Quyyumi A.A., Cannon R.O. Acute vascular effects of estrogen in postmenopausal women. Circulation. 89:1994;2251-2259.
6. Andersen H.L., Weis J.U., Fjalland B., Korsgaard N. Effect of acute and long-term treatment with 17β-estradiol on the vasomotor responses in the rat aorta. Br. J. Pharmacol. 126:1999;159-168.
7. Case J., Davison C.A. Estrogen alters relative contributions of nitric oxide and cyclooxygenase products to endothelium-dependent. J. Pharmacol. Exp. Ther. 291:1999;524-530.
8. Wiener C.P., Leizasoain I., Baylis S.A., Knowles R.G., Charles I.G., Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc. Natl. Acad. Sci. USA. 91:1994;5212-5216.
9. Chang W.C., Nakao J., Ormo H., Murota S.I. Stimulation of prostacyclin biosynthetic activity by estradiol in rat aortic smooth muscle cells in culture. Biochem. Biophys. Acta. 619:1980;107-118.
10. Polderman K.H., Stehouwer C.D., van Kamp G.J., Dekker G.A., Verheugt F.N., Gooren L.J. Influence of sex hormones on plasma endothelium levels. Ann. Int. Med. 118:1993;429-432.
11. Proudler A.J., Ahmed A.I., Crook D., Folgeoman I., Rymer I.M., Stevenson J.C. Hormone replacement therapy and serum angiotensin-converting enzyme activity in postmenopausal women. Lancet. 346:1995;89-90.
12. Rodomski M.W., Palmer R.M.J., Moncada S. An L-arginine nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA. 87:1990;5193-5197.
13. De Caterina R. Endothelial dysfunctions common denominators in vascular disease. Curr. Opin. Lipidol. 11:2000;9-23.
14. Garg U.C., Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine proliferation of cultured rat vascular smooth cells. J. Clin. Invest. 83:1989;1774-1777.
15. Joswig M., Hasch-Wunderle V., Ziegler R., Nawroth P.P. Postmenopausal hormone replacement therapy and the vascular wall: mechanisms of 17β-estradiol's effects on vascular biology. Exp. Clin. Endocrinol. Diabetes. 107:1997;477-487.
16. Goetz R., Morano I., Calovini T., Sluater R., Holtz J. Increased expression of endothelial constructive nitric oxide synthase in rat aorta during pregnancy. Biochem. Biophys. Res. Commun. 205:1994;905-910.
17. Hishikawa K., Nakaki T., Marumo T., Suzuki H., Kato R., Savuta T. Up regulation of nitric oxide-synthase by estradiol in human aortic endothelial cells. FEBS Lett. 360:1995;291-293.
18. Hayashi T., Yamada K., Esaki T., et al. Estrogen increase endothelial nitric oxide by receptor-mediated system. Biochem. Biophys. Res. Commun. 214:1995;847-855.
19. 2+ mobilization. Circ. Res. 81:1997;885-892.
20. Stefano G.B., Prevot V., Beauvillain J.C., et al. Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelial. Circulation. 101:2000;1594-1597.
21. Russell K.S., Haynes M.P., Sinha D., Clerisme E., Bender J.R. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc. Natl. Acad. Sci. USA. 97:2000;5930-5935.
22. Chen Z., Yahanna I.S., Galcheva-Garagova Z., Kara R., Mendelsohn M., Shaul W. Estrogen receptor γ mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J. Clin. Inv. 103:1999;401-406.
23. Selles J., Polini N., Alvarez C., Massheimer V. Progesterone and 17β-estradiol acutely stimulate nitric oxide synthase activity in rat aorta and inhibit platelet aggregation. Life Sci. 69:2001;815-827.
24. Hasimoto M., Ganoh S., Hossain S., et al. Age-related changes in aortic sensitivity to noradrenaline and acetylcholine in rats. Clin. Exp. Paharmacol. Physiol. 25:1998;676-681.
25. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 195:1951;265-277.
26. Honda H., Unemoto T., Kogo H. Different mechanisms for testosterone-induced relaxation of aorta between normotensive and spontaneously hypertensive rat. Hypertension. 34:1999;1232-1238.
27. Quan T.H., Leung S.W., Man R.Y. Differential effects of 17 beta-estradiol and testosterone on the contractile responses of porcine coronary arteries. Br. J. Pharmacol. 129:2000;1301-1308.
28. Hayashi T., Fukuto J.M., Ignarro L.J., Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: Implications for atherosclerosis. Proc. Natl. Acad. Sci. USA. 89:1992;11259-11263.
29. Bruck B., Brehme U., Gubel N., et al. Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscler. Thromb. Vasc. Biol. 17:1997;2192-2199.
30. Celermajer D.J., Sorensen K.E., Spiegelhalter J.D., Georgakopoulos D., Robinson J., Deanfield J.E. Aging is associated with endothelial dysfunction in healthy men years before age-related decline in women. Am. J. Coll. Cardiol. 24:1994;471-476.
31. Roselli M., Imthurn B., Keller P.J., Jackson E.K., Dubey R.K. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate. Hypertension. 25:1995;848-853.
32. Gryglewski R.J., Palmer R.M., Moncada S. Superoxide anion is involved in breakdown of endothelium-derived vascular relaxing factor. Nature. 320:1986;454-456.
33. Collins P., Shay J., Jiang C., Moss J. Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation. 90:1994;1964-1968.
34. Guillian D.M., Quyyumi A.A., Cannon R.O. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 89:1994;2545-2551.
35. Hussain M.B., Hobbs A.J., Mac Allister R.J. Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta. Br. J. Pharmacol. 128:1999;1082-1088.
36. Radomski M.W., Palmer R.M.J., Moncada S. The anti-aggregation properties of vascular endothelium; interactions between prostacyclin and nitric oxide. Br. J. Pharmacol. 92:1987;181-187.
37. Rubany G.M., Freay A.D., Kauser K., et al. Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. J. Clin. Invest. 99:1997;2429-2437.
38. Knowles R.G., Moncada S. Nitric oxide synthases in mammals. Biochem. J. 298:1994;249-258.